| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
|
Campos, Susana
|
|
|
27 |
12 |
p. 1881-1890
|
article
|
| 2 |
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study)
|
Matsuoka, Hiroshi
|
|
|
27 |
12 |
p. 1859-1866
|
article
|
| 3 |
Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study
|
Sugawara, Shunichi
|
|
|
27 |
12 |
p. 1828-1838
|
article
|
| 4 |
Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series
|
Iwasawa, Tomohiro
|
|
|
27 |
12 |
p. 1867-1873
|
article
|
| 5 |
Combining nutritional status with TNM stage: a physiological update on gastric cancer staging for improving prognostic accuracy in elderly patients
|
Sugawara, Kotaro
|
|
|
27 |
12 |
p. 1849-1858
|
article
|
| 6 |
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)
|
Shoji, Tadahiro
|
|
|
27 |
12 |
p. 1874-1880
|
article
|
| 7 |
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study
|
Sugawara, Shunichi
|
|
|
27 |
12 |
p. 1839-1840
|
article
|
| 8 |
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
|
Takahashi, Shunji
|
|
|
27 |
12 |
p. 1805-1817
|
article
|
| 9 |
Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong
|
Leung, Karen K. Y.
|
|
|
27 |
12 |
p. 1904-1915
|
article
|
| 10 |
List of reviewers 2021–2022
|
|
|
|
27 |
12 |
p. 1916-1919
|
article
|
| 11 |
Long non-coding RNA NR2F2-AS1 regulates human osteosarcoma growth and metastasis through miR-425-5p-mediated HMGB2
|
Ye, Jia
|
|
|
27 |
12 |
p. 1891-1903
|
article
|
| 12 |
Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302
|
Kasai, Takashi
|
|
|
27 |
12 |
p. 1841-1848
|
article
|
| 13 |
Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study
|
Kondo, Shunsuke
|
|
|
27 |
12 |
p. 1795-1804
|
article
|
| 14 |
Tumor–stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade
|
Sakai, Toshihiko
|
|
|
27 |
12 |
p. 1818-1827
|
article
|
Journal description